Nasal delivery of Fasudil‐modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis

AIM: Multiple sclerosis (MS) is a relapsing‐remitting inflammatory demyelinating disease that requires long‐term treatment. Although Rho kinase inhibitor Fasudil shows good therapeutic effect in experimental autoimmune encephalomyelitis (EAE), an animal model of MS, certain side effects may limit it...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Shang‐De, Liu, Chun‐Yun, Yu, Jing‐Wen, Chai, Zhi, Wang, Qing, Mi, Xi‐Ting, Song, Guo‐Bin, Li, Yan‐Hua, Yang, Peng‐Wei, Feng, Ling, Xiao, Bao‐Guo, Ma, Cun‐Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515703/
https://www.ncbi.nlm.nih.gov/pubmed/30779332
http://dx.doi.org/10.1111/cns.13111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515703/
https://www.ncbi.nlm.nih.gov/pubmed/30779332
http://dx.doi.org/10.1111/cns.13111

Ejemplares similares